Suchergebnisse - "Berger, Jean Mathieu"

PubPharm (6)

1

Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content

enthalten in: Molecules and cells | 2021

von Berger, J. | Moon, Y.

2

Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice

enthalten in: Journal of lipid research | 2017

von Berger, J. | Loza Valdes, A. | Gromada, J. | +2

3

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension

enthalten in: Atherosclerosis | 2015

von Berger, J. | Vaillant, N. | Le May, C. | +6

4

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension

enthalten in: Atherosclerosis | 2015

von Berger, J. | Vaillant, N. | Le May, C. | +6

5

Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2013

von Le May, C. | Berger, J. | Lespine, A. | +7

CommentIn: Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1452-3. - PMID 23766383

6

Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2013

von Le May, C. | Berger, J. | Lespine, A. | +7

1
[1]